Bristol-Myers Squibb Co
NYSE:BMY
Bristol-Myers Squibb Co
NYSE:BMY
Price:
43.99 USD
0.66%
Market Closed
Updated:
May 4, 2024
Bristol-Myers Squibb Co
Depreciation & Amortization
|
Bristol-Myers Squibb Co
Depreciation & Amortization Peer Comparison
Comparables:
JNJ
PFE
MRK
ZTS
LLY
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Depreciation & Amortization
-$9.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-183%
|
CAGR 10-Years
-70%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Depreciation & Amortization
-$4.9B
|
CAGR 3-Years
-78%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-1%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Zoetis Inc
NYSE:ZTS
|
Depreciation & Amortization
-$149m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-10%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Bristol-Myers Squibb Co's Depreciation & Amortization?
Depreciation & Amortization
-9.1B
USD
-9.1B
USD
Based on the financial report for Mar 31, 2024, Bristol-Myers Squibb Co's Depreciation & Amortization amounts to -9.1B USD.
What is Bristol-Myers Squibb Co's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
-70%
-70%
Over the last year, the Depreciation & Amortization growth was 3%. The average annual Depreciation & Amortization growth rates for Bristol-Myers Squibb Co have been 3% over the past three years , -183% over the past five years , and -70% over the past ten years .
You don't have any saved screeners yet
